Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Lane

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The Science of the Total Environment|August 24, 2015
A new framework for selecting environmental surrogatesDavid Lindenmayer, Jennifer Pierson, Philip Barton, et al.
Clinical Immunology (Orlando, Fla.)|February 14, 2004
Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiencyPierre Quartier, Jacinta Bustamante, Ozden Sanal, et al.
Journal of Medical Internet Research|December 5, 2019
Comparative Effectiveness of a Web-Based Patient Decision Aid for Therapeutic Options for Sickle Cell Disease: Randomized Controlled TrialLakshmanan Krishnamurti, Diana Ross, Cynthia Sinha, et al.
British Journal of Haematology|January 20, 2007
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell diseaseElliott Vichinsky, Onyinye Onyekwere, John Porter, et al.
JMIR Research Protocols|July 6, 2022
Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility StudyLakshmanan Krishnamurti, Staci D Arnold, Ann Haight, et al.
Cancer Research|January 14, 2017
RORγt<sup>+</sup> Innate Lymphoid Cells Promote Lymph Node Metastasis of Breast CancersSheeba Irshad, Fabian Flores-Borja, Katherine Lawler, et al.
Clinical and Experimental Immunology|May 31, 2022
Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UKAdrian M Shields, Ariharan Anantharachagan, Gururaj Arumugakani, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Science of the Total Environment|August 24, 2015
A new framework for selecting environmental surrogatesDavid Lindenmayer, Jennifer Pierson, Philip Barton, et al.
Clinical Immunology (Orlando, Fla.)|February 14, 2004
Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiencyPierre Quartier, Jacinta Bustamante, Ozden Sanal, et al.
Journal of Medical Internet Research|December 5, 2019
Comparative Effectiveness of a Web-Based Patient Decision Aid for Therapeutic Options for Sickle Cell Disease: Randomized Controlled TrialLakshmanan Krishnamurti, Diana Ross, Cynthia Sinha, et al.
British Journal of Haematology|January 20, 2007
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell diseaseElliott Vichinsky, Onyinye Onyekwere, John Porter, et al.
JMIR Research Protocols|July 6, 2022
Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility StudyLakshmanan Krishnamurti, Staci D Arnold, Ann Haight, et al.
Cancer Research|January 14, 2017
RORγt<sup>+</sup> Innate Lymphoid Cells Promote Lymph Node Metastasis of Breast CancersSheeba Irshad, Fabian Flores-Borja, Katherine Lawler, et al.
Clinical and Experimental Immunology|May 31, 2022
Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UKAdrian M Shields, Ariharan Anantharachagan, Gururaj Arumugakani, et al.
Pageof 3